Asia Pacific Hyperpigmentation Disorder Treatment Market
The Asia Pacific Hyperpigmentation Disorder Treatment Market size was valued at US$ 2,462.36 Mn in 2022 and is projected to reach US$ 4,468.99 Mn by 2030, growing at a CAGR of 7.7% during 2022 - 2030.
Report Coverage
- Treatment Type: Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy
- Condition: Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation
- End User: Hospitals, Dermatology Centers
US$ 2,462.36 Mn
Market size in 2022
US$ 4,468.99 Mn
Market Size by 2030
7.7%
CAGR, 2022 - 2030
2023-2030
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Asia Pacific Hyperpigmentation Disorder Treatment Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Asia Pacific Hyperpigmentation Disorder Treatment Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Asia Pacific Hyperpigmentation Disorder Treatment Market Regional Analysis
6.2 Asia Pacific Hyperpigmentation Disorder Treatment Market Revenue 2020-2030 (US$ Million)
6.3 Asia Pacific Hyperpigmentation Disorder Treatment Market Forecast Analysis
7. Asia Pacific Hyperpigmentation Disorder Treatment Market Analysis – by Treatment Type
7.1 Cosmeceutical
- 7.1.1 Overview
- 7.1.2 Cosmeceutical: Asia Pacific Hyperpigmentation Disorder Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.2 Light or Laser Therapy
- 7.2.1 Overview
- 7.2.2 Light or Laser Therapy: Asia Pacific Hyperpigmentation Disorder Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.3 Microdermabrasion
- 7.3.1 Overview
- 7.3.2 Microdermabrasion: Asia Pacific Hyperpigmentation Disorder Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.4 Chemical Peels
- 7.4.1 Overview
- 7.4.2 Chemical Peels: Asia Pacific Hyperpigmentation Disorder Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.5 Cryotherapy
- 7.5.1 Overview
- 7.5.2 Cryotherapy: Asia Pacific Hyperpigmentation Disorder Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)
8. Asia Pacific Hyperpigmentation Disorder Treatment Market Analysis – by Condition
8.1 Melasma
- 8.1.1 Overview
- 8.1.2 Melasma: Asia Pacific Hyperpigmentation Disorder Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.2 Solar Lentigines
- 8.2.1 Overview
- 8.2.2 Solar Lentigines: Asia Pacific Hyperpigmentation Disorder Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.3 Post-Inflammatory Hyperpigmentation
- 8.3.1 Overview
- 8.3.2 Post-Inflammatory Hyperpigmentation: Asia Pacific Hyperpigmentation Disorder Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)
9. Asia Pacific Hyperpigmentation Disorder Treatment Market Analysis – by End User
9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Hospitals: Asia Pacific Hyperpigmentation Disorder Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.2 Dermatology Centers
- 9.2.1 Overview
- 9.2.2 Dermatology Centers: Asia Pacific Hyperpigmentation Disorder Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)
10. Asia Pacific Hyperpigmentation Disorder Treatment Market – Asia Pacific Analysis
10.1 Overview
10.2 Asia Pacific- 10.2.1 Asia Pacific Hyperpigmentation Disorder Treatment Market Breakdown, by Key Country, 2023 and 2030 (%)
- 10.2.1.1 Asia Pacific Hyperpigmentation Disorder Treatment Market – Revenue and Forecast Analysis – by Country
- 10.2.1.1 China: Asia Pacific Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.1.1 China: Asia Pacific Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
- 10.2.1.1.2 China: Asia Pacific Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
- 10.2.1.1.3 China: Asia Pacific Hyperpigmentation Disorder Treatment Market Breakdown, by End User
- 10.2.1.2 India: Asia Pacific Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.2.1 India: Asia Pacific Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
- 10.2.1.2.2 India: Asia Pacific Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
- 10.2.1.2.3 India: Asia Pacific Hyperpigmentation Disorder Treatment Market Breakdown, by End User
- 10.2.1.3 Japan: Asia Pacific Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.3.1 Japan: Asia Pacific Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
- 10.2.1.3.2 Japan: Asia Pacific Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
- 10.2.1.3.3 Japan: Asia Pacific Hyperpigmentation Disorder Treatment Market Breakdown, by End User
- 10.2.1.4 Australia: Asia Pacific Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.4.1 Australia: Asia Pacific Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
- 10.2.1.4.2 Australia: Asia Pacific Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
- 10.2.1.4.3 Australia: Asia Pacific Hyperpigmentation Disorder Treatment Market Breakdown, by End User
- 10.2.1.5 Rest of Asia-Pacific: Asia Pacific Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.5.1 Rest of Asia-Pacific: Asia Pacific Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
- 10.2.1.5.2 Rest of Asia-Pacific: Asia Pacific Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
- 10.2.1.5.3 Rest of Asia-Pacific: Asia Pacific Hyperpigmentation Disorder Treatment Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 AbbVie Inc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Bayer AG
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Galderma SA
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 L\'OREAL S.A.
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Lutronic Co Ltd
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Obagi Cosmeceuticals LLC
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Pierre Fabre SA
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Access the Full A Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.
